tiprankstipranks
Trending News
More News >

Haleon PLC Announces Successful 2025 AGM Results

Story Highlights
Haleon PLC Announces Successful 2025 AGM Results

Confident Investing Starts Here:

The latest announcement is out from Haleon PLC Sponsored ADR ( (HLN) ).

On May 28, 2025, Haleon PLC held its 2025 Annual General Meeting, where all resolutions were passed, with resolutions 19, 20, 21, and 22 being approved as special resolutions. The meeting’s outcomes reflect strong shareholder support, with high percentages of votes in favor of the resolutions, indicating confidence in the company’s strategic direction and governance. This successful AGM reinforces Haleon’s position in the consumer health industry and suggests continued stability and potential growth, benefiting stakeholders and enhancing its market presence.

The most recent analyst rating on (HLN) stock is a Buy with a $13.40 price target. To see the full list of analyst forecasts on Haleon PLC Sponsored ADR stock, see the HLN Stock Forecast page.

Spark’s Take on HLN Stock

According to Spark, TipRanks’ AI Analyst, HLN is a Outperform.

Haleon’s strong financial performance, characterized by robust cash flow and stable profitability, is a key strength, complemented by positive technical indicators suggesting upward momentum. However, the stock’s valuation appears high, and recent earnings call highlights both opportunities in emerging markets and challenges like FX headwinds and product performance issues. These factors collectively position the stock at a solid yet cautious 73.1 score.

To see Spark’s full report on HLN stock, click here.

More about Haleon PLC Sponsored ADR

Haleon PLC is a global leader in consumer health, focusing on delivering better everyday health with humanity. The company offers a wide range of products across six major categories, including Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health. Haleon’s well-known brands such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu, and Voltaren are based on trusted science and innovation.

Average Trading Volume: 14,686,589

Technical Sentiment Signal: Buy

Current Market Cap: $50.21B

See more data about HLN stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App